Finola is a modern, auto-flowering cultivar developed from a genetic lineage encompassing Ruderalis, Auto Finny, and Charlotte's Web. Designed for accessibility, this strain is considered easy to grow, reaching maturity in a 50-day flowering period. While it performs well in both indoor and outdoor environments, growers should anticipate a low yield. This genetic foundation has proven significant for future breeding, serving as the parent to notable offspring such as CBG Auto, Finola F3, and TSU.BD Auto F3.

The sensory profile of Finola is defined by a complex arrangement of terpenes, led by a dominant presence of myrcene. This is balanced by caryophyllene and limonene, followed by secondary contributions from pinene, terpinolene, and linalool. The full expression of the plant includes lower concentrations of beta-pinene, humulene, nerolidol, ocimene, bisabolol, guaiol, camphene, caryophyllene-oxide, and p-cymene. This diverse chemical spectrum creates a nuanced aromatic experience that reflects the strain's intricate pedigree.

As a THC-dominant variety, Finola produces effects characterized by feelings of relaxation, happiness, and an uplifted state of mind. Given these reported outcomes, the strain is frequently selected by users seeking relief from stress, pain, and sleep-related concerns. Its consistent efficacy in these areas, combined with its specialized genetic background, secures its utility in both medicinal applications and as a building block for subsequent auto-flowering, cannabinoid-focused breeding projects.